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Background: Structural variants (SVs) are less common than single nucleotide polymorphisms and indels in the
population, but collectively account for a significant fraction of genetic polymorphism and diseases. Base pair
differences arising from SVs are on a much higher order (>100 fold) than point mutations; however, none of the
current detection methods are comprehensive, and currently available methodologies are incapable of providing
sufficient resolution and unambiguous information across complex regions in the human genome. To address
these challenges, we applied a high-throughput, cost-effective genome mapping technology to comprehensively
discover genome-wide SVs and characterize complex regions of the YH genome using long single molecules
(>150 kb) in a global fashion.
Results: Utilizing nanochannel-based genome mapping technology, we obtained 708 insertions/deletions and 17
inversions larger than 1 kb. Excluding the 59 SVs (54 insertions/deletions, 5 inversions) that overlap with N-base
gaps in the reference assembly hg19, 666 non-gap SVs remained, and 396 of them (60%) were verified by paired-end
data from whole-genome sequencing-based re-sequencing or de novo assembly sequence from fosmid data. Of the
remaining 270 SVs, 260 are insertions and 213 overlap known SVs in the Database of Genomic Variants. Overall, 609 out
of 666 (90%) variants were supported by experimental orthogonal methods or historical evidence in public databases.
At the same time, genome mapping also provides valuable information for complex regions with haplotypes in a
straightforward fashion. In addition, with long single-molecule labeling patterns, exogenous viral sequences were
mapped on a whole-genome scale, and sample heterogeneity was analyzed at a new level.
Conclusion: Our study highlights genome mapping technology as a comprehensive and cost-effective method for
detecting structural variation and studying complex regions in the human genome, as well as deciphering viral
integration into the host genome.
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A structural variant (SV) is generally defined as a region
of DNA 1 kb and larger in size that is different with
respect to another DNA sample [1]; examples include
inversions, translocations, deletions, duplications and in-
sertions. Deletions and duplications are also referred to
as copy number variants (CNVs). SVs have proven to be
an important source of human genetic diversity and
disease susceptibility [2-6]. Base pair differences arising
from SVs occur on a significantly higher order (>100
fold) than point mutations [7,8], and data from the 1000
Genomes Project show population-specific patterns of
SV prevalence [9,10]. Also, recent studies have firmly
established that SVs are associated with a number of
human diseases ranging from sporadic syndromes and
Mendelian diseases to common complex traits, particu-
larly neurodevelopmental disorders [11-13]. Chromosomal
aneuploidies, such as trisomy 21 and monosomy X have
long been known to be the cause of Down’s and Turner
syndromes, respectively. A microdeletion at 15q11.2q12
has been shown causal for Prader-Willi syndrome [14],
and many submicroscopic SV syndromes have been re-
vealed since then [15]. In addition, rare, large de novo
CNVs were identified to be enriched in autism spectrum
disorder (ASD) cases [16], and other SVs were described
as contributing factors for other complex traits including
cancer, schizophrenia, epilepsy, Parkinson’s disease and
immune diseases, such as psoriasis (reviewed in [11] and
[12]). With the increasing recognition of the important
role of genomic aberrations in disease and the need
for improved molecular diagnostics, comprehensive
characterization of these genomic SVs is vital for, not only
differentiating pathogenic events from benign ones, but
also for rapid and full-scale clinical diagnosis.
While a variety of experimental and computational
approaches exist for SV detection, each has its distinct
biases and limitations. Hybridization-based approaches
[17-19] are subject to amplification, cloning and
hybridization biases, incomplete coverage, and low dy-
namic range due to hybridization saturation. Moreover,
detection of CNV events by these methods provides no
positional context, which is critical to deciphering their
functional significance. More recently, high-throughput
next generation sequencing (NGS) technologies have been
heavily applied to genome analysis based on alignment/
mapping [20-22] or de novo sequence assembly (SA) [23].
Mapping methods include paired-end mapping (PEM)
[20], split-read mapping (SR) [21] and read depth analysis
(RD) [22]. These techniques can be powerful, but are tedi-
ous and biased towards deletions owing to typical NGS
short inserts and short reads [24,25]. De novo assembly
methods are more versatile and can detect a larger range
of SV types and sizes (0 ~ 25 kb) by pair-wise genome
comparison [23-25]. All such NGS-based approaches lackpower for comprehensiveness and are heavily biased against
repeats and duplications because of short-read mapping
ambiguity and assembly collapse [9,10,26]. David C.
Schwartz’s group promoted optical mapping [27] as an
alternative to detect SVs along the genome with restriction
mapping profiles of stretched DNA, highlighting the use
of long single-molecule DNA maps in genome analysis.
However, since the DNA is immobilized on glass surfaces
and stretched, the technique suffers from low throughput
and non-uniform DNA stretching, resulting in imprecise
DNA length measurement and high error rate, hindering
its utility and adoption [24,27-29]. Thus, an effective
method to help detect comprehensive SVs and reveal
complex genomic regions is needed.
The nanochannel-based genome mapping technology,
commercialized as the “Irys” platform, automatically im-
ages fluorescently labeled DNA molecules in a massively
parallel nanochannel array, and was introduced as an ad-
vanced technology [30] compared to other restriction
mapping methods because of high-throughput data col-
lection and its robust and highly uniform linearization of
DNA in nanochannels. This technology has previously
been described and used to map the 4.7-Mb highly vari-
able human major histocompatibility complex (MHC)
region [31], as well as for de novo assembly of a 2.1-Mb
region in the highly complex Aegilops tauschii genome
[32], lending great promise for use in complete genome
sequence analysis. Here, we apply this rapid and high-
throughput genome mapping method to discern genome
wide SVs, as well as explore complex regions based on
the YH (first Asian genome) [33] cell line. The workflow
for mapping a human genome on Irys requires no library
construction; instead, whole genomic DNA is labeled,
stained and directly loaded into nanochannels for im-
aging. With the current throughput, one can collect
enough data for de novo assembly of a human genome
in less than three days. Additionally, comprehensive SV
detection can be accomplished with genome mapping
alone, without the addition of orthogonal technologies
or multiple library preparations. Utilizing genome map-
ping, we identified 725 SVs including insertions/dele-
tions, inversions, as well as SVs involved in N-base gap
regions that are difficult to assess by current methods.
For 50% of these SVs, we detected a signal of variation by
re-sequencing and an additional 10% by fosmid sequence-
based de novo assembly whereas the remainder had no
signal by sequencing, hinting at the intractability of detec-
tion by sequencing. Detailed analyses showed most of the
undetected SVs (80%, 213 out of 270) could be found
overlapped in the Database of Genomic Variant (DGV)
database indicating their reliability. Genome mapping
also provides valuable haplotype information on complex
regions, such as MHC, killer cell Immunoglobulin-like re-
ceptor (KIR), T cell receptor alpha/beta (TRA/TRB) and
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help determine these hyper-variable regions’ sequences
and downstream functional analyses. In addition, with
long molecule labeling patterns, we were able to accurately
map the exogenous virus’ sequence that integrated into
the human genome, which is useful for the study of the
mechanism of how virus sequence integration leads to
serious diseases like cancer.
Data description
High-molecular weight DNA was extracted from the YH
cell line, and high-quality DNA was labeled and run on
the Irys system. After excluding DNA molecules smaller
than 100 kb for analysis, we obtained 303 Gb of data giv-
ing 95× depth for the YH genome (Table 1). For subse-
quent analyses, only molecules larger than 150 kb (223
Gb, ~70X) were used. De novo assembly resulted in a set
of consensus maps with an N50 of 1.03 Mb. We per-
formed “stitching” of neighboring genome maps that
were fragmented by fragile sites associated with nick
sites immediately adjacent to each other. After fragile
site stitching, the N50 improved to 2.87 Mb, and the as-
sembly covered 93.0% of the non-N base portion of the
human genome reference assembly hg19. Structural vari-
ation was classified as a significant discrepancy between
the consensus maps and the hg19 in silico map. Further
analyses were performed for highly repetitive regions,
complex regions and Epstein-Barr virus (EBV) integra-
tion. Supporting data is available from the GigaScience
database, GigaDB [34-36].
Analyses
Generation of single-molecule sequence motif maps
Genome maps were generated for the YH cell line by puri-
fying high-molecular weight DNA in a gel plug and label-
ing at single-strand nicks created by the Nt.BspQI nicking
endonuclease. Molecules were then linearized in nano-
channel arrays etched in silicon wafers for imaging [31,32].
From these images, a set of label locations on each DNA
molecule defined an individual single-molecule map. SingleTable 1 Molecule collection statistics under different
length thresholds
Length
cutoff (kb)
No. Molecules Total length (Gb) Estimated
depth (X)*
100 1,568,969 303 95
120 1,313,832 275 86
150 932,855 223 70
180 659,149 179 56
200 523,146 153 48
300 170,432 68 21
500 22,944 14 4
*Estimated depth based on 3.2 Gb genome size.molecules have, on average, one label every 9 kb and were
up to 1 Mb in length. A total of 932,855 molecules larger
than 150 kb were collected for a total length of 223 Gb
(~70-fold average depth) (Table 1). Molecules can be
aligned to a reference to estimate the error rates in the sin-
gle molecules. Here, we estimated the missing label rate is
10%, and the extra label rate is 17%. Most of the error asso-
ciated with these reference differences are averaged out in
the consensus de novo assembly. Distinct genetic features
intractable to sequencing technologies, such as long arrays
of tandem repeats were observed in the raw single mole-
cules (Additional file 1: Figure S1).
De novo assembly of genome maps from single-molecule
data
Single molecules were assembled de novo into consensus
genome maps using an implementation of the overlap-
layout-consensus paradigm [37]. An overlap graph was
constructed by an initial pairwise comparison of all mol-
ecules >150 kb, by pattern matching using commercial
software from BioNano Genomics. Thresholds for the
alignments were based on a p-value appropriate for the
genome size (thresholds can be adjusted for different
genome sizes and degrees of complexity) to prevent
spurious edges. This graph was used to generate a draft
consensus map set that was improved by alignment of
single molecules and recalculation of the relative label
positions. Next, the consensus maps were extended by
aligning overhanging molecules to the consensus maps
and calculating a consensus in the extended regions.
Finally, the consensus maps were compared and merged
where patterns matched (Figure 1). The result of this de
novo assembly is a genome map set entirely independent
of known reference or external data. In this case, YH was
assembled with an N50 of 1.03 Mb in 3,565 maps and an
N50 of 2.87 Mb in 1,634 maps after stitching fragile sites
(Additional file 1: Figure S2 and Additional file 1: Table
S1). These genome maps define motif positions that occur
on every 9 kb on average, and these label site positions
have a resolution of 1.45 kb. The standard deviation for
interval measurements between two labels varies with
length. For example, for a 10 kb interval, the standard de-
viation (SD) is 502 bp, and for a 100 kb interval, it is
1.2 kb. Consensus genome maps were aligned to an in
silico Nt.BspQI sequence motif map of hg19. Ninety-nine
percent of the genome maps could align to hg19 and
they overlap 93% of the non-gap portion of hg19.
Structural variation analysis
Using the genome map assembly as input, we performed
structural variation detection (Figure 1), and the genome
maps were compared to hg19. Strings of intervals be-
tween labels/nick motifs were compared and when they
diverged, an outlier p-value was calculated and SVs were
Figure 1 Flowchart of consensus genome map assembly and structural variant discovery using genome mapping data.
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generating a list of 725 SVs including 59 that overlapped
with N-base gaps in hg19 (Additional file 2, Spreadsheet
3). Based on the standard deviation of interval measure-
ments, 1.5 kb is the smallest insertion or deletion that
can be confidently measured for an interval of about
10 kb if there is no pattern change. However, if label pat-
terns deviate from the reference, SVs with a net size dif-
ference less than 1.5 kb can be detected. Additional file
1: Figure S1 shows three mapping examples (one dele-
tion, one insertion, and one inversion) of gap region SVs.
We present these 59 events separately although technic-
ally, in those cases, genome mapping detected structural
differences between the genome maps and reference re-
gions. For the remaining 666 SVs, 654 of them wereFigure 2 Size distribution of total detected large insertions (green) an
histogram bars in red and blue respectively represent deletions and insertioinsertions/deletions (Figure 2) while 12 were inversions
(Additional file 2, Spreadsheet 1 & 2). Out of the 654 in-
sertions/deletions, 503 were defined as insertions and
151 were deletions, demonstrating an enrichment of
insertions for this individual with respect to the hg19
reference (Figure 2). Of the 59 SV events that span N-
gap regions, 5 of them were inversions. Of the remaining
54 events, 51 were estimated to be shorter than indicated
and 3 longer. These gap-region related SVs indicate a spe-
cific structure of gap regions of the YH genome compared
to the hg19 reference.
In order to validate our SVs, we first cross-referenced
them with the public SV database DGV (http://dgv.tcag.
ca/dgv/app/home) [38]. For each query SV, we required
50% overlap with records in DGV. We found that thed deletions (purple) using genome mapping. The comparative
ns supported by NGS. NGS: next-generation sequencing.
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found (Additional file 2, Spreadsheet 1 & 2), confirming
their reliability. Next, we applied the NGS discordant
paired-end mapping and read depth-based methods, as
well as fosmid-based de novo assembly (See Methods for
detail), and as a result, detected an SV signal in 396
(60%, Figure 2) out of 666 SVs by at least one of the two
methods (Figure 2, Additional file 2, Spreadsheet 1 & 2).
For the remaining 270 SVs, 79% (213 out of 270, Additional
file 2, Spreadsheet 1 & 2) were found in the DGV database.
Overall, 91% (609 out of 666, Additional file 2, Spreadsheet
1 & 2) of SVs had supporting evidence by retrospectively
applied sequencing-based methods or database entries.
We wanted to determine if SVs revealed by genome
mapping, but without an NGS supported signal, had
unique properties. We firstly investigated the distribu-
tion of NGS-supported SVs and NGS-unsupported SVs
in repeat-rich and segmental duplication regions. How-
ever we did not find significant differences between
them (data not shown) which was in concordance with
previous findings [27]. We also compared the distribu-
tion of insertions and deletions of different SV categories
and found that SV events that were not supported by se-
quencing evidence were 97% (260 out of 268) insertions;
in contrast, the SVs that were supported by sequencing evi-
dence were only 61% (243 out of 396, Figure 2, Additional
file 2, Spreadsheet 1) insertions showing insertion en-
richment (p = 2.2e-16 Chi-squared test, Figure 2) in
SVs without sequencing evidence. In addition, we fur-
ther investigated the novel 57 SVs without either se-
quencing evidence or database supporting evidence.
We found that the genes they covered had important
functions, such as ion binding, enzyme activating and
so forth, indicating their important role in cellular bio-
chemical activities. Some of the genes like ELMO1,
HECW1, SLC30A8, SLC16A12, JAM3 are reported to
be associated with diseases like diabetic nephropathy,
lateral sclerosis, diabetes mellitus and cataracts [39],
providing valuable foundation for clinical application
(Additional file 2, Spreadsheet 1 & 2).
Highly repetitive regions of the human genome
Highly repetitive regions of the human genome are
known to be nearly intractable by NGS because short
reads are often collapsed, and these regions are often re-
fractory to cloning. We have searched for and analyzed
one class of simple tandem repeats (unit size ranging
from 2-13 kb) in long molecules derived from the ge-
nomes of YH (male) and CEPH-NA12878 (female). The
frequencies of these repeating units from both genomes
were plotted in comparison with hg19 (Figure 3). We
found repeat units across the entire spectrum of sizes in
YH and NA12878 while there were only sporadic peaks in
hg19, implying an under representation of copy numbervariation as described in the current reference assembly.
Furthermore, we have found a very large peak of approxi-
mately 2.5-kb repeats in YH (male, 691 copies) but not in
NA19878 (female, 36 copies; Figure 3). This was further
supported by additional genome mapping in other males
and females demonstrating a consistent and significant
quantity of male-specific repeats of 2.5 kb (unpublished).
As an example, Additional file 1: Figure S3 shows a raw
image of an intact long molecule of 630 kb with two tracts
of at least 53 copies and at least 21 copies of 2.5-kb tan-
dem repeats (each 2.5-kb unit has one nick label site, cre-
ating the evenly spaced pattern) physically linked by
another label-absent putative tandem repeat spanning
over 435 kb, and Additional file 1: Figure S4 shows con-
vincing mapping information. Unambiguously elucidating
the absolute value and architecture of such complex re-
peat regions is not possible with other short fragment or
hybridization-based methods.
Complex region analysis using genome mapping
Besides SV detection, genome mapping data also provide
abundant information about other complex regions in
the genome. For complex regions that are functionally
important, an accurate reference map is critical for precise
sequence assembly and integration for functional analysis
[40-43]. We analyzed the structure of some complex
regions of the human genome. They include MHC
also called Human leukocyte antigen (HLA), KIR,
IGL/IGH, as well as TRA/TRB [44-48]. In the highly
variable HLA-A and –C loci, the YH genome shared
one haplotype with the previously typed PGF genome
(used in hg19) and also revealed an Asian/YH-specific
variant on maps 209 and 153 (Additional file 1: Figure
S5), respectively. In the variant haplotype (Map ID
153), there is a large insertion at the HLA-A locus
while at the HLA-D and RCCX loci, YH had an Asian/
YH-specific insertion and a deletion. In addition to the
MHC region, we also detected Asian/YH-specific struc-
tural differences in KIR (Additional file 1: Figure S6),
IGH/IGL (Additional file 1: Figure S7), and TRA/TRB
(Additional file 1: Figure S8), compared to the reference
genome.
External sequence integration detection using genome
mapping
External viral sequence integration detection is import-
ant for the study of diseases such as cancer, but current
high-throughput methods are limited in discovering
integration break points [49-51]. Although fiber fluores-
cence in situ hybridization (FISH) was used to discrimin-
ate between integration and episomal forms of virus
utilizing long dynamic DNA molecules [52], this method
was laborious, low-resolution and low-throughput. Thus,
long, intact high-resolution single-molecule data provided
Figure 3 A plot of repeat units in two human genomes as seen in single molecules. A repeat unit is defined as five or more equidistant
labels. Total units in bins are normalized to the average coverage depth in the genome.
Figure 4 Circos plot of distribution of integration events
throughout YH genome. The genome was divided into
non-overlapping windows of 200 kb. The number of molecules with
evidence of integration in each window is plotted with each concentric
grey circle representing a two-fold increment in virus detection.
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of which part of the virus sequence has been integrated
into the host genome and its localization. We detected
EBV integration into the genome of the cell line sample.
The EBV virus map was assembled de novo during the
whole genome de novo assembly of the YH cell line
genome. We mapped the de novo EBV map to in silico
maps from public databases to determine the strain that
was represented in the cell line. We found that the YH
strain was most closely related, although not identical,
to strain B95-8 (GenBank: V01555.2). To detect EBV in-
tegration, portions of the aligned molecules extending
beyond the EBV map were extracted and aligned with
hg19 to determine potential integration sites (Additional
file 1: Figure S9). There are 1,340 EBV integration events
across the genome (Figure 4). We found that the frequency
of EBV integration mapping was significantly lower than
the average coverage depth (~70X), implying the DNA
sample derived from a clonal cell population is potentially
more diverse than previously thought, and that this method
could reveal the heterogeneity of a very complex sample
population at the single-molecule level. Also, the integrated
portion of the EBV genome sequence was detected with a
larger fraction towards the tail (Additional file 1: Figure
S10). Besides integration events, we also found EBV
episome molecules whose single-molecule map could be
mapped to the EBV genome, free of flanking human
genomic regions.
Discussion
Structural variants are increasingly frequently shown to
play important roles in human health. However, available
technologies, such as array-CGH, SNP array and NGS
are incapable of cataloguing them in a comprehensive
and unbiased manner. Genome mapping, a technology
successfully applied to the assembly of complex
regions of a plant genome and characterization ofstructural variation and haplotype differences in the
human MHC region, has been adopted to capture the
genome-wide structure of a human individual in the
current study. Evidence for over 600 SVs in this indi-
vidual has been provided. Despite the difficulty of SV
detection by sequencing methods, the majority of gen-
ome map-detected SVs were retrospectively found to
have signals consistent with the presence of an SV,
validating genome mapping for SV discovery. Approxi-
mately 75% of the SVs discovered by genome mapping
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method bias or a genuine representation of the additional
content in this genome of Asian descent that is not
present in hg19, which was compiled based on genomic
materials presumably derived from mostly non-Asians.
Analysis of additional genomes is necessary for compari-
son. Insertion detection is refractory to many existing
methodologies [24,25], so to some extent, genome map-
ping revealed its distinct potential to address this chal-
lenge. Furthermore, functional annotation results of the
detected SVs show that 30% of them (Additional file 2,
Spreadsheet 1 & 2) affect exonic regions of relevant genes
which may cause severe effects on gene function. Gene
ontology (GO) analysis demonstrates that these SVs are
associated with genes that contribute to important bio-
logical processes (Additional file 2, Spreadsheet 1 & 2 and
Additional file 1: Figure S11), reflecting that the SVs de-
tected here are likely to affect a large number of genes and
may have a significant impact on human health. Genome
mapping provides us with an effective way to study the
impact of genome-wide SV on human conditions. Some
N-base gaps are estimated to have longer or shorter length
or more complex structurally compared to hg19, demon-
strating that genome mapping is useful for improving the
human and other large genome assemblies. We also
present a genome-wide analysis of short tandem repeats
in individual human genomes and structural information
and differences for some of the most complex regions in
the YH genome. Independent computational analysis has
been performed to discern exogenous viral insertions, as
well as exogenous episomes. All of these provide invaluable
insights into the capacity of genome mapping as a promis-
ing new strategy for research and clinical application.
The basis for the genome mapping technology that en-
ables us to effectively address shortcomings of existing
methodologies is the use of motif maps derived from ex-
tremely long DNA molecules hundreds of kb in length.
Using these motif maps, we are able to also access
challenging loci where existing technologies fail. Firstly,
global structural variations were easily and quickly de-
tected. Secondly, evidence for a deletion bias which is
commonly observed with both arrays and NGS technol-
ogy, is absent in genome mapping. In fact, we observe
more insertions than deletions in this study. Thirdly, for
the first time, we are able to measure the length of re-
gions of the YH genome that represent gaps in the
human reference assembly. Fourthly, consensus maps
could be assembled in highly variable regions in the YH
genome which are important for subsequent functional
analysis. Finally, both integrated and un-integrated EBV
molecules are identified, and potential sub-strains differ-
entiated, and the EBV genome sequence that integrated
into the host genome was obtained directly. This infor-
mation was previously inaccessible without additionalPCR steps or NGS approaches [50]. All in all, we dem-
onstrated advantages and strong potential of the genome
mapping technology based on nanochannel arrays to
help overcome problems that have severely limited our
understanding of the human genome.
In addition to the advantages this study reveals about
the genome mapping technology, aspects that need to be
improved also are highlighted. As genome mapping tech-
nology generates sequence-specific motif-labeled DNA
molecules and analyzes these motif maps using an overlap-
layout-consensus algorithm, subsequent performance and
resolution largely depends on motif density (any individual
event endpoints can only be resolved to the nearest restric-
tion sites). For example, the EBV integration analysis in this
study was more powerful in the high-density regions
(Additional file 1: Figure S10). Hence, higher density label-
ing methods to increase the information density that may
promote even higher accuracy and unbiased analysis of ge-
nomes are currently being further developed. When data
from genome mapping is combined with another source of
information, one can achieve even higher resolution for
each event. In addition, reducing random errors like extra
restriction sites, missing restriction sites and size measure-
ment is important for subsequent analysis. Finally, improve-
ments to the SV detection algorithm will provide further
discovery potential, and balanced reciprocal translocations
can be identified in genome maps generated from cancer
model genomes (personal communication, Michael Rossi).
The throughput and speed of a technology remains
one of the most important factors for routine use in
clinical screening as well as scientific research. At the
time of manuscript submission, genome mapping of a
human individual could be accomplished with fewer
than three nanochannel array chips in a few days. It is
anticipated that a single nanochannel chip would cover
a human size genome in less than one day within
6 months, facilitating new studies aimed at unlocking
the inaccessible portions of the genome. In this way,
genome mapping has an advantage over the use of mul-
tiple orthogonal methods that are often used to detect
global SVs. Thus, it is now feasible to conduct large
population-based comprehensive SV studies efficiently
on a single platform.
Methods
High-molecular weight DNA extraction
High-molecular weight (HMW) DNA extraction was
performed as recommended for the CHEF Mammalian
Genomic DNA Plug Kit (BioRad #170-3591). Briefly,
cells from the YH or NA12878 cell lines were washed
with 2x with PBS and resuspended in cell resuspension
buffer, after which 7.5 × 105 cells were embedded in
each gel plug. Plugs were incubated with lysis buffer and
proteinase K for four hours at 50°C. The plugs were
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The purified DNA was subjected to four hours of
drop dialysis (Millipore, #VCWP04700) and quantified
using Nanodrop 1000 (Thermal Fisher Scientific) and/
or the Quant-iT dsDNA Assay Kit (Invitrogen/Mo-
lecular Probes).
DNA labeling
DNA was labeled according to commercial protocols
using the IrysPrep Reagent Kit (BioNano Genomics,
Inc). Specifically, 300 ng of purified genomic DNA was
nicked with 7 U nicking endonuclease Nt.BspQI (New
England BioLabs, NEB) at 37°C for two hours in NEB
Buffer 3. The nicked DNA was labeled with a
fluorescent-dUTP nucleotide analog using Taq polymer-
ase (NEB) for one hour at 72°C. After labeling, the nicks
were ligated with Taq ligase (NEB) in the presence of
dNTPs. The backbone of fluorescently labeled DNA was
stained with YOYO-1 (Invitrogen).
Data collection
The DNA was loaded onto the nanochannel array of
BioNano Genomics IrysChip by electrophoresis of DNA.
Linearized DNA molecules were then imaged automatic-
ally followed by repeated cycles of DNA loading using
the BioNano Genomics Irys system.
The DNA molecules backbones (YOYO-1 stained) and
locations of fluorescent labels along each molecule were
detected using the in-house software package, IrysView.
The set of label locations of each DNA molecule defines
an individual single-molecule map.
De novo genome map assembly
Single-molecule maps were assembled de novo into con-
sensus maps using software tools developed at BioNano
Genomics. Briefly, the assembler is a custom implemen-
tation of the overlap-layout-consensus paradigm with a
maximum likelihood model. An overlap graph was gen-
erated based on pairwise comparison of all molecules as
input. Redundant and spurious edges were removed.
The assembler outputs the longest path in the graph and
consensus maps were derived. Consensus maps are fur-
ther refined by mapping single-molecule maps to the
consensus maps and label positions are recalculated. Re-
fined consensus maps are extended by mapping single
molecules to the ends of the consensus and calculating
label positions beyond the initial maps. After merging of
overlapping maps, a final set of consensus maps was
generated and used for subsequent analysis. Further-
more, we applied a “stitching” procedure to join neigh-
boring genome maps. Two adjacent genome maps
would be joined together if the junction a) was within
50 kb apart, b) contained at most 5 labels, c) contained,
or was within 50 kb from, a fragile site, and d) alsocontained no more than 5 unaligned end labels. If these
criteria were satisfied, the two genome maps would be
joined together with the intervening label patterns taken
from the reference in silico map.Structural variation detection
Alignments between consensus genome maps and the
hg19 in silico sequence motif map were obtained using a
dynamic programming approach where the scoring
function was the likelihood of a pair of intervals being
similar [53]. Likelihood is calculated based on a noise
model which takes into account fixed sizing error, sizing
error which scales linearly with the interval size, mis-
aligned sites (false positives and false negatives), and
optical resolution. Within an alignment, an interval or
range of intervals whose cumulative likelihood for
matching the reference map is worse than 0.01 percent
chance is classified as an outlier region. If such a region
occurs between highly scoring regions (p-value of 10e−6),
an insertion or deletion call is made in the outlier re-
gion, depending on the relative size of the region on the
query and reference maps. Inversions are defined if adja-
cent match-groups between the genome map and refer-
ence are in reverse relative orientation.Signals refined by re-sequencing and de novo assembly
based methods
In order to demonstrate the capacity of genome mapping
for the detection of large SVs, we tested the candidate
SVs using whole-genome paired-end 100 bp sequencing
(WGS) data with insert sizes of 500 bp and fosmid se-
quence based de novo assembly result. SVs were tested
based on the expectation that authentic SVs would be
supported by abnormally mapped read pairs, and that
deletions with respect to the reference should have lower
mapped read depth than average [20,22,23]. We per-
formed single-end/(paired-end + single-end) reads ratio
(sp ratio) calculations at the whole-genome level to assign
an appropriate threshold for abnormal regions as well as
depth coverage. We set sp ratio and depth cutoff thresh-
olds based on the whole genome data to define SV signals.
Insertions with aberrant sp ratio and deletions with either
sp ratio or abnormal depth were defined to be a supported
candidate.
We also utilized fosmid-based de novo assembly data
to search for signals supporting candidate SVs. We used
contigs and scaffolds assembled from short reads to
check for linearity between a given assembly and hg19
using LASTZ [54]. WGS-based and fosmid-based SV
validation showed inconsistency and/or lack of satur-
ation as each supported unique variants (Additional file
1: Figure S2) [24].
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Single-molecule maps were aligned with a map generated
in silico based on the EBV reference sequence (strain B95-
8; GenBank: V01555.2). Portions of the aligned molecules
extending beyond the EBV map were extracted and
aligned with hg19 to determine potential integration sites.Availability of supporting data
The data sets supporting the results of this article is
available in the GigaScience GigaDB, repository [55]. See
the individual GigaDB entries for the YH Bionano data
[35] and YH fosmid validation data [36], which is also
available in the SRA [PRJEB7886].Additional files
Additional file 1: Figure S1. Comparison of consensus genome maps
and hg19 reference across gap regions. Figure S2. Consensus genome
map coverage of human reference assembly (hg19). Figure S3. Examples
of repetitive sequence detected in intact single molecules by genome
mapping. Figure S4. Consensus genome map compared to hg19 in a
long tandem repeat region. Figure S5. Consensus genome maps
compared to hg19 in the MHC region. Figure S6. Consensus genome
maps compared to hg19 in the KIR region. Figure S7. Consensus
genome maps compared to hg19 in the IGH and IGL regions. Figure S8.
Consensus genome maps compared to hg19 in the TRA and TRB regions.
Figure S9. Single-molecule alignment to EBV in silico motif map (strain
B95-8) showing evidence of strain variation and heterogeneous integration.
Figure S10. Distribution of integrated portions of the EBV genome.
Figure S11. GO annotations of genes within called SVs. Table S1. Summary
of consensus genome map assembly.
Additional file 2: Spreadsheet 1. Summary of insertions and deletions
detected in BioNano genome maps. Spreadsheet 2: Summary of
inversions detected in BioNano genome maps. Spreadsheet 3: Validation
of insertions and deletions detected in BioNano genome maps.
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